Author:
Kinter Lewis B.,Murphy Dennis J.,Macia Richard A.,Mann William A.,Solleveld Henk A.
Reference51 articles.
1. Acher, R. and Chauvet, J., 1953, La structure de 1a vasopressine de boeuf. Biochim. Biophys. Acta 12: 487–488.
2. Andersson, K. E. and Arner, B., 1972, Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus. Acta Med. Scand. 192: 21–27.
3. Anderson, R. J., Chung, H-M., Kluge, R., and Schrier, R. W., 1985, Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann. Inter. Med. 102: 164–168.
4. Allison, N. L., Albright son-Win slow, C. R., Brooks, D. P., Stassen, F. L., Huffman, W. F., Stote, R. M., and Kinter, L. B., 1988, Species heterogeneity and antidiuretic hormone antagonists: what are the predictors? In: Vasopressin: Cellular and Integrative Aspects, edited by A. W. Cowley, J-F. Liard, and D. A. Ausiello, Raven Press, Ltd., New York, pp.207–214.
5. Bankir, L. Bouby, N., and Trinh-Trang-Tan, M-M., 1991, Vasopressin-dependent kidney hypertrophy: role of urinary concentration in protein-induced hypertrophy and in the progression of chronic renal failure. Am. J. Kidney Dis. 17: 661–665.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献